Altendorfer-Kroath, T.; Hummer, J.; Kollmann, D.; Boulgaropoulos, B.; Raml, R.; Birngruber, T.
Quantification of the Therapeutic Antibody Ocrelizumab in Mouse Brain Interstitial Fluid Using Cerebral Open Flow Microperfusion and Simultaneous Monitoring of the Blood–Brain Barrier Integrity. Pharmaceutics 2023, 15, 1880.
https://doi.org/10.3390/pharmaceutics15071880
AMA Style
Altendorfer-Kroath T, Hummer J, Kollmann D, Boulgaropoulos B, Raml R, Birngruber T.
Quantification of the Therapeutic Antibody Ocrelizumab in Mouse Brain Interstitial Fluid Using Cerebral Open Flow Microperfusion and Simultaneous Monitoring of the Blood–Brain Barrier Integrity. Pharmaceutics. 2023; 15(7):1880.
https://doi.org/10.3390/pharmaceutics15071880
Chicago/Turabian Style
Altendorfer-Kroath, Thomas, Joanna Hummer, Denise Kollmann, Beate Boulgaropoulos, Reingard Raml, and Thomas Birngruber.
2023. "Quantification of the Therapeutic Antibody Ocrelizumab in Mouse Brain Interstitial Fluid Using Cerebral Open Flow Microperfusion and Simultaneous Monitoring of the Blood–Brain Barrier Integrity" Pharmaceutics 15, no. 7: 1880.
https://doi.org/10.3390/pharmaceutics15071880
APA Style
Altendorfer-Kroath, T., Hummer, J., Kollmann, D., Boulgaropoulos, B., Raml, R., & Birngruber, T.
(2023). Quantification of the Therapeutic Antibody Ocrelizumab in Mouse Brain Interstitial Fluid Using Cerebral Open Flow Microperfusion and Simultaneous Monitoring of the Blood–Brain Barrier Integrity. Pharmaceutics, 15(7), 1880.
https://doi.org/10.3390/pharmaceutics15071880
